Treatment of eruptive lichen planus with oral acyclovir
Keywords:
Key Words, Lichen planus (LP), Hepatitis B virus(HBV), Hepatitis C virus(HCV), Diabetes mellitus (DM), Upper respiratory tract infection(URTI).Abstract
Objective To measure the efficacy of oral acyclovir for treatment of eruptive lichen planus. Methods This quasi experimental study was done in outpatient department of Dermatology, Nishtar Medical University, Multan, from 01-05-2018 to 31-10-2018. Total thirty patients of eruptive lichen planus of either sex and age ranging from 18 – 65 years were included in this study. They were given oral acyclovir 400 mg three times a day for six weeks. Patients were followed up at three and six weeks and then up to three months to find out the efficacy of treatment. Results A total of 30 patients were enrolled in the study with mean age of 37.76%±13.92. Males were 46.66% and females were 53.33%. 23 out of total 30 (76.7%) patients showed effective response to oral acyclovir. Conclusion Oral Acyclovir is an effective and innovative treatment for eruptive lichen planus.References
Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med 2012;366(8):723–32.
Shengyuan L, Songpo Y, Wen W, Wenjing T, Haitao, Z,Binyou W.Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis, Arch Dermatol.2009;145:1040-1047.
Lodi G, Giuliani M, Majorana A,et al. Lichen planus and hepatitis virus:a multicenter study of patients with oral lesions and a systematic review. Br J Dermatol. 2004;151:1172-1181.
Protzer U, Ochsendorf FR,Leopolder-Ochsendorf A, Holtermuller .KH, Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology. 1993;104:903-905.
Daramola OO,George AO, Ogunbiyi AO,Otegbayo JA. Hepatitis B virus in Nigerians with lichen planus. West Afr J Med. 2004;23:104-106.
de Vries HJ, van Marle J, Teunissen MB, et al. Lichen planus is associated with human herpesvirus 7replication and infiltration of plasmacytoid dendritic cells. Br J Dermatol. 2006; 154:361-364.
Mizukawa Y, Horie C, Yamazaki Y, Shiohara T. Detection of varicella-zoster virus antigens in lesional skin of zosteriform lichen planus but not in that of linear lichen planus . Dermatology. 2012;225:22-26.
Pourshahidi S, Fakhri F, Ebrahimi H, et al. Lack of association between Helicobacter pylori infection and oral lichen planus. Asian Pac J Cancer prev.2012;13:1745-1747.
Rebora A, Rongioletti F,Drago F, Parodi A. Lichen planus as a side effect of HBV vaccination. Dermatology. 1999;198:222.
Limas C, Limas CJ. Lichen planus in children:a possible complication of hepatitis B vaccines. Pediatr Dermatol.2002;19:204-209.
Flemming J, Diaz-Caro S, Haggis E. Erruptive lichen planus triggered by acupunture. Arch Dernatol /201,147 (3):361-2.
Liu KC, Lee JY, Hsu MM, Hsu CK. The evolution of clinicopathologic features in eruptive lichen planus: a case report and review of literature. Dermatol Online J 2013;19(1):8.
Wagner G, Rose C, Sachse MM. Clinical variants of lichen planus. J Dtsch Dermatol Ges 2013;11(4):309–19.
Al-Mutairi N, Joshi A, Zaki A, Sharma AK, Nour-Eldin O. Acute generalized lichen planus treated with weekly betamethasone 5-mg oral mini-pulse therapy. J Drugs Dermatol 2005;4(2):218–20.
Fleming J, Diaz-Cano S, Higgins E. Eruptive lichen planus triggered by acupuncture. Arch Dermatol 2011;147(3):361–2.
Khandpur S, Sugandhan S, Sharma VK. Pulsed itraconazole therapy in eruptive lichen planus. J Eur Acad Dermatol Venereol 2009;23(1):98–101.
Kanzaki T, Otake N, Nagai M. Eruptive lichen planus. J Dermatol 1992;19(4):234–7.
Nahidi, Y., Tayyebi Meibodi, N., Ghazvini, K., Esmaily, H., Esmaeelzadeh, M. (2017). Association of classic lichen planus with humanherpesvirus-7 infection. International Journal of Dermatology, 56,49-53.
Nagao, Y., Kimura, K., Kawahigashi, Y., Sata, M. (2016). Successful treatment of hepatitis C virus-associated oral lichen planus by interferon-freetherapy with direct-acting antivirals. Clinical and Translational Gastroenterology, 7, e179.
Ganguly, S. (2014). A randomized, double-blind, placebo-controlled study of efficacy of oral acyclovir in the treatment of pityriasis rosea. Journal of Clinical and Diagnostic Research, 8, YC01–YC04.
De Ruiter, A., & Thin, R. N. (1994). Genital herpes. A guide to pharmacological therapy. Drugs, 47, 297–304.
Jackson, J. L., Gibbons, R., Meyer, G., Inouye, L. (1997). The effect of treating herpes zoster with oral acyclovir in preventing postherpetici neuralgia. A meta-analysis. Archives of Internal Medicine, 157, 909–912.
